Built End to End Biologics Capabilities
From mammalian cell culture through commercial manufacturing, Avid provides integrated capabilities to develop, scale, and deliver biologic therapies.
How Biologics Are Built
Biologic therapies are produced using living cells, complex processes, and tightly controlled manufacturing systems.
Avid’s capabilities are designed to support every step of this process, from early development through commercial supply, within one integrated organization.
biologics manufacturing
Mammalian Cell Culture
The foundation of biologics manufacturing
Mammalian cell culture is the core technology behind modern biologic therapies.
In this process, engineered cells such as CHO or HEK293 are used to produce complex therapeutic proteins, including monoclonal antibodies and recombinant proteins. These cells are grown under controlled conditions and optimized to consistently produce high-quality drug substance.
At Avid, mammalian cell culture underpins our entire development and manufacturing platform from cell line development through large-scale production.
Where it connects
- Cell Line Development → creating the production cell
- Process Development → optimizing growth and output
- Manufacturing → scaling production in bioreactors
From DNA to commercial supply
Integrated Development
& Manufacturing
Avid’s capabilities are designed to function as a continuous system. Each function is connected, supporting continuity across your program.
Cell Line Development
Stable, high-producing cell lines
Process Development
Scalable upstream and downstream processes
Analytical Development
Data supporting quality and regulatory submissions
Formulation Development
Stability and shelf-life optimization
Clinical Manufacturing
CGMP production for trials
Commercial Manufacturing
Validated processes and long-term supply
process
Upstream and
Downstream Expertise
Built across the full process
Upstream processing: Cell culture systems designed to maximize productivity and consistency
Downstream processing: Purification strategies aligned with product quality and regulatory expectations
Together, these capabilities form a complete, scalable manufacturing process.
approach
Platform Flexibility
Multiple approaches, one integrated team
Avid supports:
- Fed-batch manufacturing
- Perfusion systems
- Continuous processing strategies
This flexibility allows programs to align process design with molecule characteristics and long-term manufacturing goals.
commercial production
Designed for Scale
From lab to commercial production
Capabilities developed in early phases are designed to transition directly into manufacturing supporting:
- Efficient scale-up
- Consistent product quality
- Continuity across development stages
QUALITY
Quality Across Every Capability
All capabilities operate under a unified, FDA-aligned quality system ensuring:
- Consistent execution
- Regulatory readiness
- Reliable manufacturing performance
Why Us
Why Avid Bioservices
End-to-End Integration
Development and manufacturing within one system
Scientific Depth
Expertise across biologics processes and modalities
Scalable Infrastructure
Designed to support programs at every stage
U.S.-Based Operations
Domestic facilities aligned with regulatory expectations
Continuity of Execution
One team supporting your program from start to finish
See how your program
comes together
Explore our capabilities or connect with our team to design your development and
manufacturing strategy.